Skip to content

India is poised for earnings recovery in 2026, as supportive fiscal and monetary policies continue to underpin the resilience of domestic consumption. With valuations also becoming more favourable and US tariff risks potentially easing, Templeton Global Investments (TGI) is cautiously optimistic about India’s outlook following a turbulent year.

In the longer term, the fundamentals and structural themes for Indian equity investing remain very much intact. We maintain our high conviction ideas in the discretionary consumption, health care and banking sectors, among others.

Earnings recovery, less demanding valuations

The year of 2025 was marked by unprecedented global trade disruptions and geopolitical headwinds. In this environment, forward earnings estimates in India have gone through multiple downgrades throughout 2025. The current projections put India’s earnings per share (EPS) growth for fiscal year 2026 (FY26, ending in March 2026) at around 10%, slowing down from 12% in the previous year.1

For the full year of 2026, we believe EPS growth in India can recover to a mid-teen percentage level, with some positive momentum already showing in the July–September 2025 quarterly results season. Earnings revisions have also stabilised in late 2025, and estimates for one-year roll-forward EPS have been improving since September 2025 (Exhibit 1).

Exhibit 1: Brightening Forward View On Earnings

Sources: Bloomberg, Jefferies Equity Research, “Worst for the earnings trend likely behind”. 21 November 2025. There is no assurance that any estimate, forecast or projection will be realised.

Over the coming months, we expect earnings growth among domestic-facing and consumption-related sectors—such as consumer staples, consumer discretionary and autos—to accelerate in the second half of the current financial year. Entering financial year 2027 (April 2026–March 2027), earnings growth will likely be more broad-based, with resilience shown across both domestic and export-oriented sectors.

One of the key earnings drivers we will be watching is the potential expansion of margins. In broad terms, Indian companies should continue to maintain an EBITDA (earnings before interest, taxes, depreciation and amortisation) margin of around 20–22% over the current and the next financial year, with some scope for marginal improvements. Select sectors or companies may see stronger margin growth that could catalyse better earnings performance in the near term. For instance, we note that cost reduction initiatives across many cement companies are likely to lower cost and, coupled with pricing rebound from a low base and demand recovery, should lead to robust earnings growth in the next financial year.

This potential earnings recovery will come at a time when the underperformance of Indian equities in 2025 has pushed valuations down to a less demanding level.

Between January and November 2025, the MSCI India only gained 4.8%, while the MSCI Emerging Markets Index returned 30.4% and the global benchmark MSCI ACWI delivered 21.6%.2 The price-to-earnings premium of Indian equities has shrunk sizably in tandem (see Exhibit 2), and their valuations now appear more compelling, particularly relative to certain red-hot emerging markets.

Exhibit 2: MSCI India One-Year Forward P/E Premium vs. MSCI Emerging Markets

Source: FactSet, Franklin Templeton. As of October 2025. There is no assurance that any estimate, forecast or projection will be realised.

As the earnings outlook potentially brightens and valuations become more compelling, we think the stage is set for global investors to ramp up their focus on the Indian market again. In doing so, they may also benefit from policy tailwinds and an improving macro environment.

Policy benefits coming through, long-term growth intact

In 2025, the Indian government rolled out a series of fiscal policies to boost demand and stimulate growth. Chief among these is the income tax concessions targeting mainly the middle class, announced in February, and an overhaul of the goods and services tax (GST) brackets that effectively reduce rates for a large variety of products, implemented in September.

With the Reserve Bank of India (RBI) also cutting policy rates by a combined 125 basis points in 2025 amid low inflation rates, India has a palette of pro-growth policies that should yield their full effects entering 2026. Forward-looking confidence among both urban and rural consumers has been robust against this backdrop (see Exhibit 3). All told, we see sufficient policy tailwinds for consumer spending growth and private sector capex recovery going forward.

Exhibit 3: Consumer Confidence – Forward Situation Index

Source: Reserve Bank of India. As of November 2025.

External headwinds may also ease as the India–US trade relations potentially improve. Negotiations for a framework trade agreement have made ample progress as of December 2025, the success of which is expected to cut the 50% US tariffs to around 15–25%. We remain hopeful that a deal will materialise in early 2026, removing a key overhang for India’s outlook. A separate, full-fledged bilateral trade agreement is simultaneously in the works, paving the way for a stabilised trade relationship that is conducive to structural long-term growth.

All factors considered, we reiterate our view that India’s economy is well anchored by strong and resilient domestic consumption. The country can comfortably maintain its position as the world’s fastest-growing major economy, with gross domestic product (GDP) growth of around 6.5% until at least 2029 (see Exhibit 4).

Exhibit 4: India Leads the World in GDP Growth (%)

Source: International Monetary Fund forecasts, as of November 2025. There is no assurance that any estimate, forecast or projection will be realised.

Consumption and health care themes still valid

India’s positive outlook and firm economic fundamentals allow us to maintain our high conviction on sectors such as consumption, health care and banks:

  • Consumption and premiumization: Domestic consumption remains the core of India’s economic growth engine. Favourable demographics—with the youngest population among large economies—and the rise of the middle class (see Exhibit 5) will continue to drive discretionary spending and demand for more premium offerings. This may translate to opportunities in, for instance, the hotel and leisure market, where demand for luxury hotel rooms is outpacing supply, while a recovery in travel and wedding activities should lead to acceleration of revenue growth in 2026.3

Exhibit 5: The Rise of India’s Middle Class

Source: ICE360 Household Survey 2021: The Rise of India’s Middle Class 2021 Classification conversion based on Purchasing Power Parity basis. There is no assurance that any projection, estimate or forecast will be realized.

  • Health care: The health care sector is also a long-term beneficiary of India’s consumption growth and rising income levels. Sustained momentum in health care spending should continue to support hospital expansion. A 40% capacity growth (in terms of bed numbers) is projected for India’s top 12 listed hospitals. Additionally, India’s pharmaceutical revenue is set to rise over the next three years, driven mainly by GLP-1-related launches.4
  • Banks: In addition to rate cuts, the RBI in 2025 also engaged in cash reserve ratio cuts, liquidity infusion and the easing of financial regulations. Together with the tax reforms discussed above, we see favourable conditions for both consumer and corporate credit growth in 2026. Banks should also see gradual improvement in net interest margin, as rate cuts continue to deliver funding cost benefits in the coming quarters.5


Copyright ©2025. Franklin Templeton. All rights reserved.

This document is intended to be of general interest only. This document should not be construed as individual investment advice or offer or solicitation to buy, sell or hold any shares of fund. The information provided for any individual security mentioned is not a sufficient basis upon which to make an investment decision. Investments involves risks. Value of investments may go up as well as down and past performance is not an indicator or a guarantee of future performance. The investment returns are calculated on NAV to NAV basis, taking into account of reinvestments and capital gain or loss. The investment returns are denominated in stated currency, which may be a foreign currency other than USD and HKD (“other foreign currency”). US/HK dollar-based investors are therefore exposed to fluctuations in the US/HK dollar / other foreign currency exchange rate. Please refer to the offering documents for further details, including the risk factors.

The data, comments, opinions, estimates and other information contained herein may be subject to change without notice. There is no guarantee that an investment product will meet its objective and any forecasts expressed will be realized. Performance may also be affected by currency fluctuations. Reduced liquidity may have a negative impact on the price of the assets. Currency fluctuations may affect the value of overseas investments. Where an investment product invests in emerging markets, the risks can be greater than in developed markets. Where an investment product invests in derivative instruments, this entails specific risks that may increase the risk profile of the investment product. Where an investment product invests in a specific sector or geographical area, the returns may be more volatile than a more diversified investment product. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from use of this document or any comment, opinion or estimate herein. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any share class with “(Hedged)” in its name will attempt to hedge the currency risk between the base currency of the Fund and the currency of the share class, although there can be no guarantee that it will be successful in doing so. In some cases, investors may be subject to additional risks.

Please contact your financial advisor if you are in doubt of any information contained herein.

For UCITS funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the UCITS Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive.

For AIFMD funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the AIFMD Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 32a of the AIFMD Directive.

For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the fund(s)/ sub-fund(s) and will not be investing directly in the underlying assets of the fund(s)/ sub-fund(s).

This document is issued by Franklin Templeton Investments (Asia) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.

Unless stated otherwise, all information is as of the date stated above. Source: Franklin Templeton.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.